Director Epidemiology
AstraZeneca
Disclosure(s): AstraZeneca: Employee of AstraZeneca and may hold stock and/or stock options
Della Varghese, PhD, MS, PharmD, is a Director and lead epidemiologist on the COVID mAbs portfolio at AstraZeneca (Vaccines and Immune Therapies) primarily focusing on real-world effectiveness and burden of illness studies in the US, Europe and other markets. In her prior AZ position, Della provided pharmaco-epidemiological support for the Enhertu Breast Cancer team successfully delivering on real-world evidence needs to support key launches, providing epidemiological expertise to fill critical gaps and communicating the value proposition of the studies across the asset portfolio. Prior to AZ, Della was working with a health economics and outcomes research consulting firm for over 4 years, designing and delivering on real-world studies across a breadth of therapeutic areas including oncology, mental health, rare diseases, and chronic conditions. Initially trained as a pharmacist, Della went on to obtain her PhD in health economics and MS in pharmaco-epidemiology from Virginia Commonwealth University, Richmond, Va, USA.